FlexifyMe, a healthtech startup, secures funding from ah! Ventures

• ByStartupStory     |    December 22, 2023

Healthtech startup FlexifyMe has secured an undisclosed amount of funding from ah! Ventures Angel Platform, with the aim of advancing its AI motion coach. The funds will be utilized to enhance the coach’s availability in local languages and expand the platform’s reach in the MENA and North American regions. This financial boost is expected to accelerate FlexifyMe’s growth trajectory, as stated by Manjeet Singh, Co-founder of FlexifyMe, who expressed, “We’re committed to leveraging technology to improve the lives of millions suffering from chronic pain, and this funding takes us a significant step closer to achieving that goal.”

Ah! Ventures has a robust track record, having made 209 investments in 125 startups to date. The total investment portfolio of ah! Ventures now stands at Rs 434 crore (~$54 million), featuring 16 successful exits and 48 follow-on rounds. In 2023 alone, the venture has made 55 investments across all three platforms and the fund.

FlexifyMe boasts a notable lineup of backers, including Flipkart Ventures GSF, iHub Anubhuti, Chandigarh Angels (CAN), Venture Catalyst, OneCapital, and various individual investors. The startup has demonstrated remarkable growth, experiencing nearly a fivefold increase in the past 12 months.

The infusion of capital aligns with FlexifyMe’s dedication to leveraging technology for the betterment of those grappling with chronic pain. The Co-founder further emphasized the significance of the funding, stating that it brings them a step closer to their goal. The startup’s commitment to enhancing its AI motion coach and expanding its linguistic accessibility reflects a strategic approach to addressing health needs in diverse regions.

Ah! Ventures’ continued support and substantial investment portfolio underscore its commitment to fostering innovation in the startup ecosystem. With a focus on impactful technologies, FlexifyMe’s funding round is indicative of the ongoing momentum in the healthtech sector and the investor community’s confidence in its potential.

Follow Startup Story